Dudediligence.

Cytek Biosciences, Inc

CTKBNASDAQ · Laboratory Analytical Instruments
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$51.5MSep ’24$57.5MDec ’24$41.5MMar ’25$45.6MJun ’25$52.3MSep ’25$62.1MDec ’25$44.1MMar ’26$48.1MJun ’26
Net income, by quarter
$941,000Sep ’24$9.6MDec ’24−$11.4MMar ’25−$5.6MJun ’25−$5.5MSep ’25−$44.1MDec ’25−$18.9MMar ’26−$12.2MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$128.0M$164.0M$193.0M$200.5M$201.5M
Gross profit$79.1M$101.0M$109.4M$111.1M$104.5M
Operating income$9.2M−$1.8M−$27.8M−$20.5M−$40.4M
Net income$3.0M$2.5M−$12.1M−$6.0M−$66.5M
Operating cash flow$4.6M−$12.2M$5.3M$25.4M−$4.7M
Free cash flow$266,000−$22.0M$633,000$21.9M−$8.8M
Cash$364.6M$296.6M$167.3M$98.7M$90.9M
Shares outstanding133.7M135.4M130.7M129.2M128.6M